Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

by Laurie Adami

Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.

by Anna Goshua

Experts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population.

by Kevin McLaughlin

The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.

by Kate Yandell

African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

by Jon Kelvey

Amid continued research showing the impact of COVID-19 on people with cancer, patients are asking when they should get a COVID-19 vaccine.

by Marci A. Landsmann

The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.

by Anna Azvolinsky